In the United States in 2022, stroke accounted for 1 in 6 deaths related to cardiovascular disease, according to the Centers for Disease Control and Prevention (CDC). The incidence rate of stroke experienced a slight decrease from 41.1 per 100,000 in 2021 to 39.5 per 100,000 in 2022. Ischemic strokes make up approximately 87% of […]
Sign up for alerts and stay informed on the latest published guidelines, FDA decisions, and more! Copyright © 2024 Guideline Central, All Rights Reserved.
Sign up for alerts and stay informed on the latest published guidelines, FDA decisions, and more! Copyright © 2024 Guideline Central, All Rights Reserved.
The chronic and progressive nature of chronic obstructive pulmonary disease (COPD) is frequently marked by exacerbations, which are clinically defined as episodes of worsening respiratory symptoms such as dyspnea, cough, increased sputum production, and heightened sputum purulence. These exacerbations not only diminish the quality of life for individuals with COPD but also hasten disease advancement, […]
Diabetic retinopathy, the most prevalent microvascular complication of both type 1 and type 2 diabetes, stands as a primary contributor to new cases of vision impairment among individuals aged 20 to 74 in the United States. This condition serves as the ocular manifestation of end-organ damage in diabetes mellitus. Factors that heighten the risk of […]
Prostate cancer continues to be the most prevalent non-cutaneous cancer among men in the United States (US), with an estimated 268,490 new cases and 34,500 deaths projected for 2022. Given that the majority of newly diagnosed prostate cancer patients present with localized disease, it is crucial to provide evidence-based guideline statements to guide clinical decision-making […]
Constipation is a prevalent gastrointestinal disorder, affecting approximately 15% of the global population. It is more commonly diagnosed in North America and Europe compared to Asia, likely due to variations in diet, culture, and environment. Risk factors for constipation include age over 65, female gender, sedentary lifestyle, low socioeconomic status, low-fiber diet, and non-White race. […]
A list of clinical practice guidelines and guideline summaries that were updated or published in September 2024.
A list of all the FDA approved medications in September 2024.
In our most recent edition of the Guidelines Timelines, we will be exploring the topic of stroke rehabilitation. In August 2024, the Department of Veterans Affairs (VA) and the Department of Defense (DoD) jointly released an updated clinical practice guideline (CPG) for the management of stroke rehabilitation for their healthcare providers. This new guideline serves […]
In this installment of our Guidelines Timelines Series, we will be conducting a comparative analysis of the American College of Gastroenterology’s (ACG) 2024 guideline on Alcohol-Associated Liver Disease in contrast to their previous 2018 version. Alcohol-associated liver disease (ALD) stands as a prominent cause of preventable liver-related morbidity and mortality on a global scale, including […]
In this edition of our Guidelines Timeline series, we will explore the recently released 2024 Guideline for the Primary Prevention of Stroke by the American Heart Association (AHA) and American Stroke Association (ASA). This updated guideline supersedes the previous version from 2014, providing clinicians with a comprehensive resource to aid in the implementation of prevention […]
Among all women in the United States, breast cancer is the second most common cancer and the second leading cause of cancer-related deaths. In 2023, an estimated 43,170 women lost their lives to breast cancer. The incidence of breast cancer has been gradually increasing among women aged 40 to 49 years from 2000 to 2015, […]
Breast cancer remains one of the most common cancers affecting women worldwide, with early detection playing a pivotal role in successful treatment and survival rates. Early-stage breast cancer, confined to the breast or nearby lymph nodes, presents opportunities for intervention that can significantly improve patient outcomes. In this article, we delve into the evolving landscape […]
Intra-abdominal infections (IAIs) remain a major clinical challenge, requiring precise management strategies. Over the years, guidelines from the Surgical Infection Society (SIS) have provided clinicians with evidence-based strategies to improve patient outcomes. The 2024 update of the SIS guideline on the Management of Intra-Abdominal Infection focuses on refining existing recommendations and providing new insights. For […]
A list of all the FDA approved medications in September 2024.
A list of clinical practice guidelines and guideline summaries that were updated or published in September 2024.
Childhood obesity is a prevalent chronic disease affecting children today, with a complex etiology involving genetic, physiological, environmental, and socioeconomic factors. The increase in childhood obesity rates in the United States has been significant, rising from approximately 5% in the 1960s to over 19% according to recent estimates. This condition greatly increases the risk of […]
The American Urological Association (AUA) stands as the leading urologic association, offering invaluable support to the global urologic community and its 23,000 members. Their mission is to advance the highest standards of urological clinical care through education, research, and the development of healthcare policies. AUA’s Clinical Practice Guidelines provide evidence-based guidance with a clear scope […]
Hemophilia A and B, the most common severe hereditary bleeding disorders, arise from deficiencies in factor VIII and factor IX, respectively. These conditions result in prolonged bleeding episodes, which can occur spontaneously or with minimal trauma, depending on the level of factor activity. Apart from treating acute bleeding, prophylaxis is a key strategy in hemophilia […]
A list of clinical practice guidelines and guideline summaries that were updated or published in August 2024.
A list of all the FDA approved medications in August 2024.
The American Academy of Ophthalmology (AAO) is the largest association of eye physicians and surgeons globally. Their mission is to protect vision and enhance quality of life by establishing the benchmarks for ophthalmic education and championing the interests of patients and the general public. AAO regularly releases Preferred Practice Pattern® guidelines (PPP) aimed at defining […]
Affecting more than one-third of adults in the US, obesity remains a pressing health challenge for both providers and patients, conferring significant risk for comorbidities such as type 2 diabetes, obstructive sleep apnea, and cardiovascular disease. While lifestyle modifications and medical therapies, including anti-obesity medications (AOM), can be effective for some, they often fall short […]
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by systemic inflammation primarily affecting the synovial joints. This condition arises from an aberrant immune response targeting the synovium, leading to persistent inflammation, joint damage, and potential systemic manifestations. If left untreated, RA can cause significant damage to the joints and surrounding tissues, potentially leading to […]